Chad Harman is the Chief Operating Officer at NeuraSeed BCI, focusing on advancing technologies for the delivery of psychedelic pharmaceuticals in mental health treatment. Previously, Chad served as the CEO of Psycheceutical Bioscience, Inc., where innovative approaches to healthcare were developed. With over 25 years of experience in cannabis, healthcare, and biotech, Chad has held leadership positions at True Lab and Ainnova Tech, among others. Chad’s contributions have been recognized in notable publications like Forbes and Benzinga, and they actively advocate for the potential of psychedelics in addressing mental health crises. Currently, Chad is also pursuing studies at the University of Phoenix.
This person is not in the org chart
This person is not in any teams
This person is not in any offices